Trials / Completed
CompletedNCT04481230
Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer
Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan Tracer: Phase I Clinical Trial
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study is a phase I clinical trial aimed to determine the recommended dose of 99mTc-NTP 15-5 to obtain the best tracer joints contrast on images without any toxicity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 99mTc-NTP 15-5 at a diagnostic activity of 5 MBq/kg | 1 intravenous injection of 99mTc-NTP 15-5 at a diagnostic activity of 5 MBq/kg (D0) |
| DRUG | 99mTc-NTP 15-5 at a diagnostic activity of 10 MBq/kg | 1 intravenous injection of 99mTc-NTP 15-5 at a diagnostic activity of 10 MBq/kg (D0) |
| DRUG | 99mTc-NTP 15-5 at a diagnostic activity of 15 MBq/kg | 1 intravenous injection of 99mTc-NTP 15-5 at a diagnostic activity of 15 MBq/kg (D0) |
Timeline
- Start date
- 2020-11-12
- Primary completion
- 2022-07-28
- Completion
- 2022-09-19
- First posted
- 2020-07-22
- Last updated
- 2024-10-01
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04481230. Inclusion in this directory is not an endorsement.